Health Canada says it has revised regulations for precursor chemicals and manufacturing equipment used in the production of illegal synthetic drugs like fentanyl and methamphetamine as another step to strengthen border security and disrupt the illegal drug trade.
The amended regulations under the Controlled Drugs and Substances Act mandate compulsory reporting of suspicious transactions related to precursors.
The changes expand the criteria for the sale of specific health products that include ephedrine or pseudoephedrine, aiming to reduce the likelihood of diversion to illicit markets, according to information published in the government’s Canada Gazette. Both ephedrine and pseudoephedrine have an established history of misuse and diversion to the illegal production of methamphetamine, the Dec. 17 post says….